Rankings
▼
Calendar
CRMD Q2 2016 Earnings — CorMedix Inc. Revenue & Financial Results | Market Cap Arena
CRMD
CorMedix Inc.
$529M
Q2 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$16,511
Gross Profit
-$170,681
-1033.7% margin
Operating Income
-$5M
-29751.2% margin
Net Income
-$5M
-29597.5% margin
EPS (Diluted)
$-0.67
QoQ Revenue Growth
-60.1%
Cash Flow
Operating Cash Flow
-$4M
Free Cash Flow
-$4M
Stock-Based Comp.
$286,111
Balance Sheet
Total Assets
$31M
Total Liabilities
$3M
Stockholders' Equity
$28M
Cash & Equivalents
$12M
← FY 2016
All Quarters
Q3 2016 →
